Anti-inflammatory effects of apoprotein AI are mediated via modulating macrophage polarity

Chinese Journal of Cardiology

Volumn 42, Issue 2, 2014, Pages 132-135

  Li, Quanzhong ^a   Zhai, Zhenli ^a   Ma, Weihong ^a   Qian, Zongjie ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein A I; Atherosclerosis; Inflammation; Macrophages

Indexed keywords

ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN A1; CD16 ANTIGEN; CD32 ANTIGEN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CELL POLARITY; CELL STIMULATION; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; MACROPHAGE; MOUSE; NONHUMAN; UPREGULATION;

ANIMALS; APOLIPOPROTEIN A-I; CELL LINE; FEMALE; INTERFERON REGULATORY FACTORS; INTERLEUKIN-10; INTERLEUKIN-12; LECTINS, C-TYPE; MACROPHAGES; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; TOLL-LIKE RECEPTOR 4;

EID: 84896286498     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2014.02.007     Document Type: Article

References (15)

1. Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Atherosclerosis as an inflammatory disease[J]. Curr Pharm Des, 2012, 18: 4266-4288.
2. Ley K, Miller Y I, Hedrick C C. Monocyte and macrophage dynamics during atherogenesis[J]. Arterioscler Thromb Vasc Biol, 2011: 31: 1506-1516.
3. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veriias[J]. J Clin Invest, 2012, 122: 787-795.
4. Stöger J L, Gijbels M J, van der Velden S, et al. Distribution of macrophage polarization markers in human atherosclerosis[J]. Atherosclerosis, 2012, 225: 461-468.
5. Khallou-Laschet J, Varthaman A, Fornasa G, et al. Macrophage plasticity in experimental atherosclerosis[J]. PLoS One, 2010, 5: e8852.
6. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance[J]. Arterioscler Thromb Vase Biol, 2009, 29: 1419-1423.
7. Feig J E, Rong J X, Shamir R, et al. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells[J]. Proc Natl Acad Sci USA, 2011, 108: 7166-7171.
8. Gupta H, Dai L, Datta G, et al. Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide[J]. Circ Res, 2005, 97: 236-243.
9. Kim K D, Lim H Y, Lee H G, et al. Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation[J]. Biochem Biophys Res Commun, 2005, 338: 1126-1136.
10. Pradel L C, Mitchell A J, Zarubica A, et al. ATP-binding cassette transporter hallmarks tissue macrophages and modulates cytokine-triggered polarization programs[J]. Eur J Immunol, 2009, 39: 2270-2280.
11. 2013, 93: 2071-2073.
12. Fisher E A, Feig J E, Hewing B, et al. High-density lipoprotein function, dysfunction, and reverse cholesterol transport[J]. Arterioscler Thromb Vase Biol, 2012, 32: 2813-2820.
13. Ma L, Dong F, Zaid M, et al. ABCA-I protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation[J]. J Biol Chem, 2012, 287: 40502-40512.
14. Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors[J]. Nature, 2005, 434: 243-249.
15. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and T(H)1-T(H)17 responses. Nat Immunol. 2011, 12: 231-238.